ALEXA NEILL-SCHEER: Open Payments
NPI 1295572931 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$632 in 29 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $155 · 2025 $632
Food & beverage: $555Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $234 |
| ABBVIE INC. | 1 | $77 |
| Regeneron Healthcare Solutions, Inc. | 2 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Intercept Pharmaceuticals, Inc. | 2 | $35 |
| Ipsen Biopharmaceuticals, Inc | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, XIFAXAN, OCALIVA, IQIRVO, OMVOH, REZDIFFRA.
Industry payments across NE — which companies pay providers there.
